Serina Therapeutics Q2 EPS $0.51, Sales $51.00K Up From $7.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Serina Therapeutics (AMEX:SER) reported Q2 earnings of $0.51 per share and sales of $51.00K, a 628.57% increase from $7.00K YoY.
August 09, 2024 | 8:20 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Serina Therapeutics reported strong Q2 earnings with EPS of $0.51 and a significant YoY sales increase of 628.57%, reaching $51.00K.
The substantial YoY increase in sales and positive EPS indicate strong financial performance, likely boosting investor confidence and positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100